Lilly Drn (LILY34)
BOV
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 7.3B | 6.96B | 8.31B | 9.5B | 9.35B | 8.77B | 11.3B | 11.44B |
Operating Income | 1.87B | 1.49B | 2.13B | -3.24B | 2.4B | 2.51B | 4.15B | 1.61B |
Pre Tax Income | 2.1B | 1.53B | 2.09B | 427.2M | 2.51B | 2.54B | 3.52B | 1.59B |
Net Income | 1.94B | 1.34B | 1.76B | -57.4M | 2.19B | 2.24B | 2.97B | 970.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 1.94B | 1.61B | 2.23B | -3.12B | 2.48B | 2.65B | 4.26B | 1.7B |
EBITDA | 2.25B | 1.86B | 2.49B | -2.82B | 2.79B | 2.91B | 4.56B | 2.07B |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 21.22B | 22.87B | 24.56B | 22.32B | 24.56B | 28.32B | 28.54B | 34.12B |
Operating Income | 3.71B | 2.61B | 3.99B | 5.47B | 6.06B | 6.66B | 7.37B | 6.46B |
Pre Tax Income | 3.37B | 2.2B | 3.8B | 5.27B | 7.23B | 6.16B | 6.81B | 6.55B |
Net Income | 2.74B | -204.1M | 3.23B | 8.32B | 6.19B | 5.58B | 6.24B | 5.24B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 2.485 | -0.185 | 3.056 | 8.683 | 6.471 | 5.835 | 6.569 | 5.52 |
EBIT | 3.71B | 2.72B | 4.18B | 6.08B | 7.56B | 7B | 7.73B | 6.89B |
EBITDA | 5.12B | 4.05B | 5.5B | 6.51B | 7.25B | 8.08B | 8.89B | 7.99B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.